Gene · 60485
Papers1,483
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,483
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correction: The Hippo signalling pathway and its implications in human health and diseases. | Signal Transduct Target Ther | 2024 | 38172156 | PubTator, text mining | PubMed |
| Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer. | Int J Biol Sci | 2024 | 38164167 | PubTator, text mining | PubMed |
| Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. | Noncoding RNA Res | 2024 | 38125753 | PubTator, text mining | PubMed |
| Regulation of Hippo-YAP/CTGF signaling by combining an HDAC inhibitor and 5-fluorouracil in gastric cancer cells. | Toxicol Appl Pharmacol | 2024 | 38086440 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa. | J Clin Invest | 2024 | 38051587 | PubTator, text mining | PubMed |
| KIRREL promotes the proliferation of gastric cancer cells and angiogenesis through the PI3K/AKT/mTOR pathway. | J Cell Mol Med | 2024 | 37909722 | PubTator, text mining | PubMed |
| Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine. | Genes Dis | 2024 | 37692482 | PubTator, text mining | PubMed |
| Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk. | Genes Dis | 2024 | 37588235 | PubTator, text mining | PubMed |
| The potential role of Hippo pathway regulates cellular metabolism via signaling crosstalk in disease-induced macrophage polarization. | Front Immunol | 2023 | 38274792 | PubTator, text mining | PubMed |
| Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer. | Front Immunol | 2023 | 38235137 | PubTator, text mining | PubMed |
| Therapeutic significance of tumor microenvironment in cholangiocarcinoma: focus on tumor-infiltrating T lymphocytes. | Explor Target Antitumor Ther | 2023 | 38213535 | PubTator, text mining | PubMed |
| Cellular Impacts of Striatins and the STRIPAK Complex and Their Roles in the Development and Metastasis in Clinical Cancers (Review). | Cancers (Basel) | 2023 | 38201504 | PubTator, text mining | PubMed |
| Roles and functions of IAV proteins in host immune evasion. | Front Immunol | 2023 | 38152399 | PubTator, text mining | PubMed |
| Virus-Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays. | Viruses | 2023 | 38140653 | PubTator, text mining | PubMed |
| Predicting the Impact of OTOF Gene Missense Variants on Auditory Neuropathy Spectrum Disorder. | Int J Mol Sci | 2023 | 38139069 | PubTator, text mining | PubMed |
| Impaired Expression of the Salvador Homolog-1 Gene Is Associated with the Development and Progression of Colorectal Cancer. | Cancers (Basel) | 2023 | 38136317 | PubTator, text mining | PubMed |
| Unleashing the Power of Yes-Associated Protein in Ferroptosis and Drug Resistance in Breast Cancer, with a Special Focus on Therapeutic Strategies. | Cancers (Basel) | 2023 | 38136274 | PubTator, text mining | PubMed |
| Hippo Signaling Mediates TGFβ-Dependent Transcriptional Inputs in Cardiac Cushion Mesenchymal Cells to Regulate Extracellular Matrix Remodeling. | J Cardiovasc Dev Dis | 2023 | 38132651 | PubTator, text mining | PubMed |
| Hippo pathway in intestinal diseases: focusing on ferroptosis. | Front Cell Dev Biol | 2023 | 38130953 | PubTator, text mining | PubMed |
| Pharmacological inhibition of CLK2 activates YAP by promoting alternative splicing of AMOTL2. | Elife | 2023 | 38126343 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60485/papers?page=4